196 related articles for article (PubMed ID: 1680784)
1. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis.
Woods AL; Hall PA; Shepherd NA; Hanby AM; Waseem NH; Lane DP; Levison DA
Histopathology; 1991 Jul; 19(1):21-7. PubMed ID: 1680784
[TBL] [Abstract][Full Text] [Related]
2. Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma.
Visakorpi T
J Pathol; 1992 Sep; 168(1):7-13. PubMed ID: 1360498
[TBL] [Abstract][Full Text] [Related]
3. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
4. Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: correlation with 5-bromo-2'-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis.
He W; Meyer JS; Scrivner DL; Koehm S; Hughes J
Biotech Histochem; 1994 Jul; 69(4):203-12. PubMed ID: 7918835
[TBL] [Abstract][Full Text] [Related]
5. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis. A. L. Woods, P. A. Hall, N. A. Shepherd, A. M. Hanby, N. H. Waseem, D. P. Lane & D. A. Levison. Histopathology 1991; 19; 21-27.
Levison DA
Histopathology; 2002 Sep; 41(3A):162-3, discussion 163-4. PubMed ID: 12405948
[No Abstract] [Full Text] [Related]
6. Flow cytometric characterisation of proliferating cell nuclear antigen using the monoclonal antibody PC10.
Wilson GD; Camplejohn RS; Martindale CA; Brock A; Lane DP; Barnes DM
Eur J Cancer; 1992; 28A(12):2010-7. PubMed ID: 1358156
[TBL] [Abstract][Full Text] [Related]
7. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
8. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen and S phase fraction in endometrial stromal sarcoma.
Schofield JB; Mansi J; Camplejohn RS; Lane DP; Fisher C
J Clin Pathol; 1992 Aug; 45(8):664-7. PubMed ID: 1357005
[TBL] [Abstract][Full Text] [Related]
10. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.
Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA
Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840
[TBL] [Abstract][Full Text] [Related]
11. The proliferative fraction in lymph nodes: a comparison of proliferating cell nuclear antigen morphometry to flow cytometry.
Krauss JS; Pantazis CG; Chandler FW
Ann Clin Lab Sci; 1992; 22(3):189-96. PubMed ID: 1354428
[TBL] [Abstract][Full Text] [Related]
12. PC10 monoclonal antibody to proliferating cell nuclear antigen as probe for cycling cell detection in developing tissues. A combined immunocytochemical and flow cytometric study.
Casasco A; Giordano M; Danova M; Casasco M; Icaro Cornaglia A; Calligaro A
Histochemistry; 1993 Mar; 99(3):191-9. PubMed ID: 7684034
[TBL] [Abstract][Full Text] [Related]
13. Comparison of three cell cycle associated antigens as markers of proliferative activity and prognosis in breast carcinoma.
Gillett CE; Barnes DM; Camplejohn RS
J Clin Pathol; 1993 Dec; 46(12):1126-8. PubMed ID: 7904274
[TBL] [Abstract][Full Text] [Related]
14. PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes.
Galand P; Del Bino G; Morret M; Capel P; Degraef C; Fokan D; Feremans W
Leukemia; 1995 Jun; 9(6):1075-84. PubMed ID: 7596173
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?
Thomas H; Nasim MM; Sarraf CE; Alison MR; Love S; Lambert HE; Price P
Br J Cancer; 1995 Feb; 71(2):357-62. PubMed ID: 7841053
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
17. Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity.
Gelb AB; Kamel OW; LeBrun DP; Warnke RA
Am J Pathol; 1992 Dec; 141(6):1453-8. PubMed ID: 1281622
[TBL] [Abstract][Full Text] [Related]
18. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors.
Linden MD; el-Naggar AK; Nathanson SD; Jacobson G; Zarbo RJ
Mod Pathol; 1996 Jun; 9(6):682-9. PubMed ID: 8782208
[TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen immunolocalization in gastro-intestinal epithelia.
Sarraf CE; McCormick CS; Brown GR; Price YE; Hall PA; Lane DP; Alison MR
Digestion; 1991; 50(2):85-91. PubMed ID: 1687136
[TBL] [Abstract][Full Text] [Related]
20. The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer.
Fontanini G; Macchiarini P; Pepe S; Ruggiero A; Hardin M; Bigini D; Vignati S; Pingitore R; Angeletti CA
Cancer; 1992 Sep; 70(6):1520-7. PubMed ID: 1355398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]